Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

BACKGROUND: Readministering a second epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in patients with lung adenocarcinoma with acquired resistance to an initial EGFR TKI is a common treatment strategy. However, the prognostic factors for the second EGFR TKI are still uncertai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chih-Jen, Tsai, Ming-Ju, Hung, Jen-Yu, Tsai, Ying-Ming, Lee, Jui-Ying, Chou, Shah-Hwa, Liu, Ta-Chih, Shen, Mei-Chiou, Huang, Ming-Shyan, Chong, Inn-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801161/
https://www.ncbi.nlm.nih.gov/pubmed/27042119
http://dx.doi.org/10.2147/OTT.S100169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801161/
https://www.ncbi.nlm.nih.gov/pubmed/27042119
http://dx.doi.org/10.2147/OTT.S100169

Ejemplares similares